反応式
[F:1][C:2]([F:16])([F:15])[C:3]1[N:12]=[C:11]([NH:13][NH2:14])[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[N:4]=1.[CH3:17][C:18]1[CH:23]=[CH:22][C:21]([C:24](=O)[CH3:25])=[CH:20][CH:19]=1>>[C:18]1([CH3:17])[CH:23]=[CH:22][C:21]([C:24](=[N:14][NH:13][C:11]2[C:10]3[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=3)[N:4]=[C:3]([C:2]([F:1])([F:15])[F:16])[N:12]=2)[CH3:25])=[CH:20][CH:19]=1参加物
3
実験手順
The title compound was prepared from (2-trifluoromethyl-quinazolin-4-yl)-hydrazine (250 mg, 1.1 mmol) and 4′-methylacetophenone (0.22 mL, 1.6 mmol) by a procedure similar to Example 1, step 4 yielding 225 mg (60%) of a yellow solid. HPLC Purity: 95%.
出典と根拠
- ORDレコード
- ord-11c0bab9bdb44b1396a859d1e188a678
- 出典データセット
- uspto-grants-2012_10
- 特許番号
- US08288398B2
関連ノート
読み込み中…